sameAs
P184
A double blind trial of sulpiride in Huntington's disease and tardive dyskinesiaHereditary geniospasm: linkage to chromosome 9q13-q21 and evidence for genetic heterogeneityPhysiological and pathological tremors and rhythmic central motor controlCorticocortical inhibition in human motor cortexA genetic study of idiopathic focal dystoniasNomifensine in Parkinson's diseaseEffect of experimental ischemia on neurotransmitter amines in the gerbil brain"On-off" effects in patients with Parkinson's disease on chronic levodopa therapyLetter: Chorea and torsion in parkinsonismAmantadine-induced heart-failureExtrapyramidal side-effects of metoclopramideDystonia induced by combined treatment with L-dopa and MK-801 in parkinsonian monkeysStereotyped behaviour patterns and hyperactivity induced by amphetamine and apomorphine after discrete 6-hydroxydopamine lesions of extrapyramidal and mesolimbic nucleiSodium valproate in the treatment of levodopa-induced dyskinesia.Bromocriptine treatment in Parkinson's diseasePsychiatric symptoms during l-dopa therapy for Parkinson's disease and their relationship to physical disabilityThe interaction of clonidine with dopamine-dependent behaviour in rodentsDopa-responsive dystonia: long-term treatment response and prognosisSickness due to levodopa-induced neck dyskinesias in Parkinson's diseaseAnticonvulsant-induced dyskinesias: a comparison with dyskinesias induced by neurolepticsMetoclopramide and pimozide in Parkinson's disease and levodopa-induced dyskinesiasInduction of purposeless chewing behaviour in rats by 5-HT agonist drugsMyopathy associated with anticonvulsant osteomalaciaComparative trial of benzhexol, amantadine, and levodopa in the treatment of Parkinson's diseaseEarly onset of the "on-off" phenomenon in children with symptomatic ParkinsonismSSRI-induced reversal of levodopa benefit in two patients with dopa-responsive dystoniaNon-invasive electrical and magnetic stimulation of the brain, spinal cord and roots: basic principles and procedures for routine clinical application. Report of an IFCN committeeThe use of botulinum toxin in the treatment of adductor spasmodic dysphonia.The effect of posture on the normal and pathological auditory startle reflexMotor inhibition from the brainstem is normal in torsion dystonia during REM sleep.Writer's cramp.Co-localization of P450 enzymes in the rat substantia nigra with tyrosine hydroxylase.Drop attacks.Corticobasal degeneration look-alikes.Alpha-tocopherol levels in brain are not altered in Parkinson's disease.Brain, skeletal muscle and platelet homogenate mitochondrial function in Parkinson's disease.Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia.A genetic study of torsion dystonia.Sexual function in patients with Parkinson's disease and their partnersSaccadic function in spasmodic torticollis
P50
Q24515363-A1C93607-6512-47A5-8BE3-66DC0ADFB589Q24678061-B07BF8AF-3051-4360-8EF8-1FBB87F993A3Q28141585-EE280C3A-47DF-4206-BF5E-407C61946C4FQ28250305-2ABA126F-F557-42D9-8981-BC0FCF394059Q28280905-5CB861E9-FF4B-40E8-9DE6-F9728D845753Q28296394-70A94ED9-6B10-4617-888B-45E2A194CF9CQ28317347-83FC7720-7982-4D9F-A9D6-C13479578507Q28317866-86B72B44-E962-4880-B4E0-BDD30465AE08Q28317925-51E3728D-2D09-49D8-905B-FC33489A9896Q28318100-E6E24EA8-B07C-4AF0-AFF8-A5CC8BB1F218Q28318379-AC6197F3-9C2A-4A9A-A33C-C4DA964C8A97Q28321165-8856AE6B-38E4-4979-B1D8-6610A5B288E8Q28323867-3B5472DA-B9C7-46DB-AF17-7DD098DA97F8Q28324464-43BB012C-A167-4A49-8BF3-AB1108EB3F51Q28328929-011F5817-E366-4F9F-A84A-7097C5357636Q28329007-A23BBDB7-0652-4731-89E2-96555AD6A693Q28329817-99180417-693B-49A3-B2AA-30FB07FCA17FQ28333266-0C3BFFF2-00B3-4772-B7D8-9FA498740970Q28335081-DC4FBDDC-DBD0-458D-A688-2CC3B5F4CA9CQ28335688-B75A6BF3-4959-4FC6-BBDC-F20651292C97Q28336736-D2CAB597-DCC2-47B4-8975-01BF2D9FBF4DQ28341907-ACD24836-A424-482B-ABAC-37AE6AF4958AQ28362792-37BB6C00-EA86-4695-A7DF-79CEF3004E24Q28364195-21F5135A-C8B4-4B33-84EC-B2FC69F27DA8Q28367684-044A8A28-5240-4CD2-8A0B-D28AD4F6BB29Q28373136-3150712D-B2FF-4FD5-9722-41A62ADB556AQ29028595-41440973-6CE0-4747-AD57-0DE293D0E8B9Q30495787-AFDE087B-7BF5-4CC4-9407-4D72BAC7BB0EQ30495817-B9544622-7BBC-4270-9646-25FE8B33EF5BQ30495826-9F1E354B-CCE3-4089-8B80-0F211410C675Q30530601-28640A7C-6F97-4EA4-87F4-3977688BD4B4Q31937342-AE1F6AEE-BBC5-43F6-AA15-8DB2CA09938CQ33174888-32B0A944-2F0E-4F2A-9B39-47A6007C9BFAQ33179417-ABC934E5-1E4D-45F1-B2B9-7EF26D4DE67EQ33194048-B06C4496-EE60-44A1-9B6E-B09D02C9F476Q33220863-61D3A096-96A9-4BE2-8B2A-403F88D043EDQ33322579-551E65DA-E883-41C8-A462-764AB3324A46Q33586351-6AFF1811-EE4D-4742-8151-3BAA56C9A0D0Q33588940-FC6BCEA2-6950-435D-995A-9D65A2F2A002Q33588956-7EAEBF53-6FCF-4AFF-88FE-C19B5EAA7AA8
P50
description
English neurologist and neuroscientist
@en
neuroloog
@nl
name
C David Marsden
@nl
C. David Marsden
@fr
David Marsden
@de
David Marsden
@en
David Marsden
@es
type
label
C David Marsden
@nl
C. David Marsden
@fr
David Marsden
@de
David Marsden
@en
David Marsden
@es
altLabel
C D Marsden
@en
C David Marsden
@en
C Marsden
@en
C. D. Marsden
@en
C. David Marsden
@en
C. Marsden
@en
Charles David Marsden
@en
D Marsden
@en
D. Marsden
@en
Marsden C
@en
prefLabel
C David Marsden
@nl
C. David Marsden
@fr
David Marsden
@de
David Marsden
@en
David Marsden
@es
P1006
P214
P227
P244
P268
P269
P1006
P106
P1153
35404899200
P1412
P1415
P166
P185
P19
P21
P213
0000 0003 8170 9726